Send feedback

PTEN p.Arg378fs

c.1133_1136del · rs1064794878 · VCV421055

Uncertain significance Expert panel
Classification
Uncertain significance
ClinVar
Review
Expert panel ★★★☆
ClinVar · 7 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Conditions
3
PTEN hamartoma tumor syndrome

ClinGen expert panel — PTEN VCEP

Uncertain Significance for PTEN hamartoma tumor syndrome. Applied ACMG criteria (verbatim):

PM2_Supporting PM4

Curation rationale (ClinGen, verbatim)

NM_000314.8(PTEN):c.1133_1136del (p.Arg378IlefsTer37) is currently classified as a variant of uncertain significance for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (ACMG Classification Rules Specified for PTEN Variant Curation version 3.0.0). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). PM2_P: Absent in large sequenced populations (PMID 27535533). PM4: Variant causes protein extension (NM_000314.4)

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function in a haploinsufficient gene (ClinGen)
NMDescapespremature termination codon in the last exon (9 of 9) — the truncated protein is likely expressed. PVS1 input, not an applied code
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 7.9GERP 1.6, phastCons 1
Region caveats
Repeat contextseg dup · reads may not map uniquely · confidence, not pathogenicity

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,178,884 alleles
Overall 6.85e-05% 1/1,459,880 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PTEN
Protein
p.Arg378fs
Coding
c.1133_1136del
MANE Select
NM_000314
dbSNP
rs1064794878
Type
Deletion
Location
chr10:87965390 (GRCh38)
Gene constraint
LOEUF 0.685 · pLI 0.05 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 83.76 · 12 PDB
Residue 378
a UniProt-annotated variant site (in mcephas); the 'disordered' region
Full PTEN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

PTEN hamartoma tumor syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: Cowden syndrome 1hereditary neoplastic syndrome

For PTEN hamartoma tumor syndrome (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pten-p-arg378fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown